V-erbA requires auxiliary proteins for dominant negative activity
- PMID: 8093812
V-erbA requires auxiliary proteins for dominant negative activity
Abstract
The avian v-erbA protein is an important example of a dominant negative oncogene. It has been identified as a highly mutated form of its cellular homolog, the thyroid hormone receptor alpha (TR-alpha), and its biological activity has been correlated with its repressor function on certain receptor-regulated genes. Although v-erbA has lost the hormone responsiveness of its cellular homolog, it has retained DNA-binding activity, and it has been implied that this function is required for repression and transformation. Here we demonstrate that v-erbA forms heterodimers with the retinoid X receptor (RXR-alpha). Only heteromeric v-erbA-RXR-alpha complexes show DNA-binding strong enough to account for its potent repressor function. In addition, v-erbA-RXR-alpha heterodimers specifically bind natural thyroid hormone-responsive elements (TREs) but not retinoic acid-responsive elements (RAREs). Repression of TRE-controlled gene expression by v-erbA requires the presence of RXR-alpha with the natural TREs tested. In contrast, natural RAREs investigated here do not bind the v-erbA-RXR-alpha heterodimer and also are not significantly repressed by v-erbA. Carboxy-terminal mutations that abolish v-erbA-RXR-alpha heterodimer formation also abolish v-erbA repressor activity. These data suggest that interaction of v-erbA with RXRs or similar auxiliary receptors is essential for the dominant negative activity of the v-erbA oncogene.
Similar articles
-
The oncoprotein P75gag-v-erbA represses thyroid hormone induced transcription only via response elements containing palindromic half-sites.Oncogene. 1996 Aug 15;13(4):843-52. Oncogene. 1996. PMID: 8761306
-
The v-erbA oncogene requires cooperation with tyrosine kinases to arrest erythroid differentiation induced by ligand-activated endogenous c-erbA and retinoic acid receptor.Oncogene. 1992 Feb;7(2):203-16. Oncogene. 1992. PMID: 1347913
-
Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.Oncogene. 1997 Aug 7;15(6):701-15. doi: 10.1038/sj.onc.1201208. Oncogene. 1997. PMID: 9264411
-
The leukaemia oncogene v-erbA: a dominant negative version of ligand dependent transcription factors that regulates red cell differentiation?Cancer Surv. 1992;14:169-80. Cancer Surv. 1992. PMID: 1358441 Review.
-
Factors influencing nuclear receptors in transcriptional repression.Semin Cancer Biol. 1994 Oct;5(5):337-46. Semin Cancer Biol. 1994. PMID: 7849262 Review.
Cited by
-
Large-scale analysis by SAGE reveals new mechanisms of v-erbA oncogene action.BMC Genomics. 2007 Oct 26;8:390. doi: 10.1186/1471-2164-8-390. BMC Genomics. 2007. PMID: 17961265 Free PMC article.
-
Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.EMBO J. 1998 Dec 15;17(24):7382-94. doi: 10.1093/emboj/17.24.7382. EMBO J. 1998. PMID: 9857194 Free PMC article.
-
Formation of retinoid X receptor homodimers leads to repression of T3 response: hormonal cross talk by ligand-induced squelching.Mol Cell Biol. 1993 Dec;13(12):7698-707. doi: 10.1128/mcb.13.12.7698-7707.1993. Mol Cell Biol. 1993. PMID: 8246986 Free PMC article.
-
A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily.Mol Cell Biol. 1994 Oct;14(10):7025-35. doi: 10.1128/mcb.14.10.7025-7035.1994. Mol Cell Biol. 1994. PMID: 7935418 Free PMC article.
-
Mutations that alter ligand-induced switches and dimerization activities in the retinoid X receptor.Mol Cell Biol. 1994 Jun;14(6):4311-23. doi: 10.1128/mcb.14.6.4311-4323.1994. Mol Cell Biol. 1994. PMID: 8196667 Free PMC article.